<doc>
  <docmeta id="113hr2003ih">
    <bill congress="113" type="hr" number="2003" version="ih"/>
    <revision size="2287" annotations="0" status="complete" id="3" commit-time="2013-07-06T22:43:24Z" committer="mbohmer" doc="113hr2003ih/3.xml">
      <description>Edited via AKN</description>
    </revision>
  </docmeta>
  <bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="H47A98C8CA27D4CC584D8019D383774C5" public-private="public">
	<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>113 HR 2003 IH: Gluten in Medicine Disclosure Act of 2013</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2013-05-15</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">I</distribution-code>
		<congress>113th CONGRESS</congress>
		<session>1st Session</session>
		<legis-num>H. R. 2003</legis-num>
		<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber>
		<action>
			<action-date date="20130515">May 15, 2013</action-date>
			<action-desc>
        <sponsor name-id="R000577">Mr. Ryan of Ohio</sponsor> (for
			 himself and <cosponsor name-id="L000480">Mrs. Lowey</cosponsor>) introduced the
			 following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and
			 Commerce</committee-name>
      </action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To amend the Federal Food, Drug, and Cosmetic Act to
		  require the label of drugs intended for human use to contain a parenthetical
		  statement identifying the source of any ingredient constituting or derived from
		  a grain or starch-containing ingredient.</official-title>
	</form>
	<legis-body id="H7922E536CBA64081AA5D76ECB3E2CD13" style="OLC">
		<section id="H82ED6525519141A19A41ACE029376250" section-type="section-one">
      <enum>1.</enum>
      <header>Short title</header>
      <text display-inline="no-display-inline">This Act may be cited as the
			 <quote>
          <short-title>Gluten in Medicine Disclosure Act of
			 2013</short-title>
        </quote>.</text>
		</section>
    <section id="H78036728D87A47DDB50E3FCBDE29F2B3">
      <enum>2.</enum>
      <header>Labeling of
			 source of human drug ingredients constituting or derived from a grain or
			 starch-containing ingredient</header>
			<subsection id="H7E7B6A236F544F89A8024D245B9F3200">
        <enum>(a)</enum>
        <header>Misbranding</header>
        <text display-inline="yes-display-inline">
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:502">Section 502 of the Federal Food, Drug, and
			 Cosmetic Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/352">21 U.S.C. 352</external-xref>)</cato:entity> is amended by adding at the end the
			 following:</text>
				<quoted-block display-inline="no-display-inline" id="H0627F49808E042AC94FB590880A7BA59" style="OLC">
					<subsection id="H0308DED8E3BA4182A00637A22AAC5B47">
            <enum>(bb)</enum>
            <text display-inline="yes-display-inline">If it is a drug—</text>
						<paragraph id="H47D7B3DAA3A74BAFAB7D851EF0B1EA8A">
              <enum>(1)</enum>
              <text>that is intended
				for human use;</text>
						</paragraph>
            <paragraph id="HFF3C4557D06142E6BCE5BA9E59001624">
              <enum>(2)</enum>
              <text>that contains an
				ingredient (other than a polyol) that constitutes or is derived from a grain or
				starch-containing ingredient; and</text>
						</paragraph>
            <paragraph id="H42DADA6FB01E4395BEF2DDB3435BF7AB">
              <enum>(3)</enum>
              <text>whose label fails
				to include a parenthetical statement identifying the source of the ingredient
				so constituted or
				derived.</text>
						</paragraph>
          </subsection>
          <after-quoted-block>.</after-quoted-block>
        </quoted-block>
			</subsection>
      <subsection id="H1130E66C4199443DA6DD97B60073F02F">
        <enum>(b)</enum>
        <header>Applicability</header>
        <text display-inline="yes-display-inline">
          <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:502/ss:bb">Section 502(bb) of the Federal Food, Drug,
			 and Cosmetic Act</cato:entity-ref>, as added by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Gluten in Medicine Disclosure Act of 2013/s:2/ss:a" proposed="true">subsection (a) of this section</cato:entity-ref>, shall apply
			 beginning on the sooner of—</text>
				<paragraph id="HAA75A6D0A61846BB8180A13535B86C7B">
          <enum>(1)</enum>
          <text>a
			 date to be determined by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary of Health and Human Services</cato:entity-ref>; and</text>
				</paragraph>
        <paragraph id="HEC9CC6E5D90148888E0F0118C7872D11">
          <enum>(2)</enum>
          <text>the date that is 2
			 years after the date of the enactment of this Act.</text>
				</paragraph>
      </subsection>
    </section>
  </legis-body>
</bill>
</doc>